41 research outputs found
Applications of lignin in the agri-food industry
Of late, valorization of agri-food industrial by-products and their sustainable utilization is
gaining much contemplation world-over. Globally, 'Zero Waste Concept' is promoted with
main emphasis laid towards generation of minimal wastes and maximal utilization of plantbased
agri-food raw materials. One of the wastes/by-products in the agri-food industry are the
lignin, which occurs as lignocellulosic biomass. This biomass is deliberated to be an
environmental pollutant as they offer resistance to natural biodegradation. Safe disposal of this
biomass is often considered a major challenge, especially in low-income countries. Hence, the
application of modern technologies to effectively reduce these types of wastes and maximize
their potential use/applications is vital in the present day scenario. Nevertheless, in some of the
high-income countries, attempts have been made to efficiently utilize lignin as a source of fuel, as a raw material in the paper industry, as a filler material in biopolymer based packaging and
for producing bioethanol. However, as of today, agri-food industrial applications remains
significantly underexplored. Chemically, lignin is heterogeneous, bio-polymeric, polyphenolic
compound, which is present naturally in plants, providing mechanical strength and rigidity.
Reports are available wherein purified lignin is established to possess therapeutic values; and
are rich in antioxidant, anti-microbial, anti-carcinogenic, antidiabetic properties, etc.
This chapter is divided into four sub-categories focusing on various technological
aspects related to isolation and characterization of lignin; established uses of lignin; proved
bioactivities and therapeutic potentials of lignin, and finally on identifying the existing research
gaps followed by future recommendations for potential use from agri-food industrial wastes.Theme of this chapter is based on our ongoing project- Valortech,
which has received funding from the European Union’s Horizon 2020 research and innovation
program under grant agreement No 810630
Pan-cancer analysis of whole genomes
Cancer is driven by genetic change, and the advent of massively parallel sequencing has enabled systematic documentation of this variation at the whole-genome scale(1-3). Here we report the integrative analysis of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA). We describe the generation of the PCAWG resource, facilitated by international data sharing using compute clouds. On average, cancer genomes contained 4-5 driver mutations when combining coding and non-coding genomic elements; however, in around 5% of cases no drivers were identified, suggesting that cancer driver discovery is not yet complete. Chromothripsis, in which many clustered structural variants arise in a single catastrophic event, is frequently an early event in tumour evolution; in acral melanoma, for example, these events precede most somatic point mutations and affect several cancer-associated genes simultaneously. Cancers with abnormal telomere maintenance often originate from tissues with low replicative activity and show several mechanisms of preventing telomere attrition to critical levels. Common and rare germline variants affect patterns of somatic mutation, including point mutations, structural variants and somatic retrotransposition. A collection of papers from the PCAWG Consortium describes non-coding mutations that drive cancer beyond those in the TERT promoter(4); identifies new signatures of mutational processes that cause base substitutions, small insertions and deletions and structural variation(5,6); analyses timings and patterns of tumour evolution(7); describes the diverse transcriptional consequences of somatic mutation on splicing, expression levels, fusion genes and promoter activity(8,9); and evaluates a range of more-specialized features of cancer genomes(8,10-18).Peer reviewe
Poultry offal meal as a protein supplement for grower pigs
A 16-week feeding trial, involving 18 weaner pigs in a randomized complete block design, was carried out to determine. the value of poultry offal meal (POM) as a protein supplement for grower pigs at three dietary levels, 0%, 10% and 20%. Liveweight gain, dressing percentage and backfat thickness were significantly (<0.05) higher in pigs fed 20%POM dietary level. The cut parts, heart, liver and kdney, , also increased with increasing level of POM), the diets. The poultry offal meal (POM), the processed, edible and inedible parts of poultry (viscera feathers, beaks blood, discarded eggs and dead birds) used for this study, contained 56 .4% crude protein 20.9% crude fat , 7 .7% total ash. 4.6% crude fibre and 3 J 8Kcal/gm metabolizable energy. The results of this study suggest that POM could be incorporated in grower pig rations up to 20% with good results.Key words: Poultry offal meal (POM), protein supplement